Community-Based Surveillance of Antimicrobial Use and ...

3. Vellore, IndiaWhen the use of selected classes of ABMs is represented on a monthly basis, by either thepercentage of prescriptions containing one ABM from the class (Figure 3.6) or the DDD per100 patients seen (Figure 3.7), very little variation was discernible in either of the timeperiods studied.Fig. 3.6 (A-D): Monthly use of ABM expressed as percentage of prescriptions with specific ABMduring phases 1a and 1b (2003-2005)Phase 1a Aug 2003 - Jul 2004 Phase 1b Jan 2005 - Dec 200520A1. Cotrimoxazole (2003-4)UrbanRuralAverage20A2. Cotrimoxazole (2005)UrbanRuralAverage% prescriptions with ABM151050Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul% prescriptions with ABM151050Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec% prescriptions with ABM20151050B1. Extended-spectrum penicillins (2003-4)UrbanRuralAverage% prescriptions with ABM20151050B2. Extended-spectrum penicillins (2005)UrbanRuralAverageAug Sep Oct Nov Dec Jan Feb Mar Apr May Jun JulJan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec20C1. Fluoroquinolones (2003-4)UrbanRuralAverage20C2. Fluoroquinolones (2005)UrbanRuralAverage% prescriptions with ABM15105% prescriptions with ABM151050Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul0Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec% prescriptions with ABM2015105D1. Tetracyclines (2003-4)UrbanRuralAverage% prescriptions with ABM2015105D2. Tetracyclines (2005)%UrbanRuralAverage0Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul0Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec37